{
    "nct_id": "NCT05320406",
    "official_title": "Mechanism and Predictors of Cardiotoxicity After Prostate Cancer Treatment: a Parallel Cohort and Randomized Trial Comparing Radiation Alone, Radiation Plus Leuprolide, and Radiation Plus Relugolix",
    "inclusion_criteria": "* Men >= 18 years old\n* Non-metastatic prostate cancer\n* Non-metastatic, biochemically recurrent prostate cancer\n* Plan to undergo curative-intent pelvic radiation therapy with or without ADT\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Metastatic prostate cancer requiring > 24 months of ADT\n* Prior exposure to androgen deprivation therapy\n* Prior exposure to chemotherapy or immunotherapy\n* History of cardiac bypass surgery or percutaneous coronary intervention",
    "miscellaneous_criteria": ""
}